Bellevue Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-598,046
| Closed | -$19.5M | – | 161 |
|
|
2023
Q1 | $19.5M | Buy |
598,046
+1,854
| +0.3% | +$60.5K | 0.28% | 81 |
|
|
2022
Q4 | $32.9M | Sell |
596,192
-60,996
| -9% | -$3.36M | 0.44% | 66 |
|
|
2022
Q3 | $29.1M | Sell |
657,188
-44,880
| -6% | -$1.99M | 0.42% | 63 |
|
|
2022
Q2 | $34.2M | Buy |
702,068
+577,107
| +462% | +$28.1M | 0.48% | 61 |
|
|
2022
Q1 | $6.08M | Buy |
124,961
+3,800
| +3% | +$185K | 0.07% | 112 |
|
|
2021
Q4 | $5.17M | Sell |
121,161
-8,128
| -6% | -$347K | 0.05% | 126 |
|
|
2021
Q3 | $4.96M | Buy |
+129,289
| New | +$4.96M | 0.05% | 130 |
|